Guidance on amendments to the Food and Drug Regulations for drugs for use in relation to COVID-19: Post-market requirements
The only amendment related to post-market regulation is the Minister’s new (continued) authority to impose terms and conditions for a designated COVID-19 drug (C.01.014.21).
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2021-07-29
Data overview
- Formats
- HTML
- File languages
- English, French